GB1140387A - 4,5,6,7-tetrahydro-thiazolo-[5,4-c]pyridines - Google Patents
4,5,6,7-tetrahydro-thiazolo-[5,4-c]pyridinesInfo
- Publication number
- GB1140387A GB1140387A GB31938/66A GB3193866A GB1140387A GB 1140387 A GB1140387 A GB 1140387A GB 31938/66 A GB31938/66 A GB 31938/66A GB 3193866 A GB3193866 A GB 3193866A GB 1140387 A GB1140387 A GB 1140387A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkenyl
- aryl
- alkyl
- cycloalkyl
- aralkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F9/00—Component parts of dredgers or soil-shifting machines, not restricted to one of the kinds covered by groups E02F3/00 - E02F7/00
- E02F9/20—Drives; Control devices
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Mining & Mineral Resources (AREA)
- Civil Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Structural Engineering (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
1,140,387. Tetrahydro - thiazolo - [5,4c]- pyridines. DR. KARL THOMAE, G.m.b.H. 15 July, 1966 [23 July, 1965], No. 31938/66. Heading C2C. [Also in Division A5] Novel compounds of the formula (wherein R 1 is H, C 1-6 alkyl, C 2-6 alkenyl, halo C 2-6 alkenyl, C 3-8 cycloalkyl, C 6-10 aryl, C 7-9 aralkyl, aromatic or aliphatic carboxylic or sulphonic acyl, carbamoyl or amidino; R 2 is H, C 1-6 alkyl, C 2-6 alkenyl, halo C 2-6 alkenyl, or cycloalkyl, or NR 1 R 2 is a heterocyclic ring which may contain a further hetero atom and/or be OH, methyl or phenyl substituted; R 3 is H, C 1-6 alkyl, C 2-6 alkenyl, halo C 2-6 alkenyl, C 3-8 cycloalkyl, C 6-10 aryl, C 7-9 aralkyl, aromatic or aliphatic carboxylic or sulphonic acyl, carbamoyl, thiocarbamoyl or amidino; and where alkyl groups R 1 , R 2 and/or R 3 may be OH, alkoxy, aryloxy, cycloalkyl, carboxy, carbalkoxy or amido substituted, and aromatic groups R 1 , R 2 and/or R 3 may be halogen, OH, alkyl, alkoxy, alkylthio, alkylsulphonyl, alkylenedioxy, amino, alkylamino, acylamino or aminosulphonyl substituted. R 4 and R 5 are H, alkyl, aryl or aralkyl; and R is a bond or a C 1-3 hydrocarbon chain) and acid-addition salts thereof, are prepared from hydrohalic acid salts of the appropriate 3-bromo-4-piperidones and thioureas or thioamides. Products wherein R 3 is aryl may be hydrolysed, provided R 1 is not aryl, to the corresponding compounds wherein R 3 is H, which compounds may in turn be reacted with appropriate reagents to replace the H atom R 3 by another radical or group R 3 (except aryl).
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DET0029055 | 1965-07-23 | ||
DET0032991 | 1967-01-16 | ||
DET0032993 | 1967-01-16 | ||
DET0032992 | 1967-01-16 | ||
DET0032990 | 1967-01-16 | ||
DET0032994 | 1967-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1140387A true GB1140387A (en) | 1969-01-15 |
Family
ID=27512321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB31938/66A Expired GB1140387A (en) | 1965-07-23 | 1966-07-15 | 4,5,6,7-tetrahydro-thiazolo-[5,4-c]pyridines |
Country Status (7)
Country | Link |
---|---|
BE (1) | BE684415A (en) |
BR (1) | BR6681517D0 (en) |
DE (1) | DE1620508A1 (en) |
ES (9) | ES329299A1 (en) |
FR (3) | FR6013M (en) |
GB (1) | GB1140387A (en) |
NL (2) | NL6610324A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2173187A (en) * | 1985-03-23 | 1986-10-08 | Erba Farmitalia | Condensed 2-substituted thiazole derivatives |
US4624956A (en) * | 1983-12-16 | 1986-11-25 | Farmitalia Carlo Erba | Ulcer and gastric secretion inhibiting 4,5,6,7-tetrahydrothiazole[5,4-c]pyridine derivatives |
US4847264A (en) * | 1982-07-21 | 1989-07-11 | Rorer Pharmaceutical Corporation | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
WO2004083218A1 (en) * | 2003-03-20 | 2004-09-30 | Actelion Pharmaceuticals Ltd | Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
US7291734B2 (en) | 2002-11-14 | 2007-11-06 | Novartis Ag | N-sulfonylaminothiazole |
US7547786B2 (en) | 2003-11-12 | 2009-06-16 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
WO2010071822A1 (en) * | 2008-12-19 | 2010-06-24 | Schering Corporation | Piperidine and piperazine derivatives and methods of use thereof |
WO2010114971A1 (en) * | 2009-04-03 | 2010-10-07 | Sepracor Inc. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
US8541592B2 (en) | 2005-11-22 | 2013-09-24 | Amgen Inc. | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3680929D1 (en) | 1985-02-06 | 1991-09-26 | Boehringer Ingelheim Kg | USE OF 2-AMINO-6-ALLYL-5,6,7,8-TETRAHYDRO-4H-THIAZOLO (4,5-D) AZEPINE FOR THE PRODUCTION OF A TREATMENT FOR PARKINSON'S DISEASE OR. MEDICINAL PRODUCT SUITABLE FOR PARKINSONISM. |
US5060904A (en) * | 1987-05-01 | 1991-10-29 | David Hegarty | Multi-positionable support stand with movable center of gravity and article holding means |
DE69818094T2 (en) * | 1997-12-11 | 2004-07-08 | Biochem Pharma Inc., Laval | ANTIVIRAL CONNECTIONS |
SE0001899D0 (en) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
RS44304A (en) | 2001-11-22 | 2007-06-04 | Biovitrum Ab., | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
JP6890179B2 (en) | 2016-12-02 | 2021-06-18 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Bicyclic amide compounds and how to use them |
UA125448C2 (en) | 2017-07-14 | 2022-03-09 | Ф. Хоффманн-Ля Рош Аг | BICYCLIC KETONE COMPOUNDS AND METHODS OF THEIR APPLICATION |
PE20211247A1 (en) * | 2017-10-31 | 2021-07-13 | Hoffmann La Roche | SULFONES AND BICYCLE SULFOXIDES AND METHODS OF USING THEM |
CN109134510A (en) * | 2018-11-13 | 2019-01-04 | 井冈山大学 | Prepare 2- amino -5-CBZ-4, the new method of 5,6,7- tetrahydro-thiazoles simultaneously [5,4-C] pyridine |
-
1965
- 1965-07-23 DE DE19651620508 patent/DE1620508A1/en active Pending
-
1966
- 1966-07-15 GB GB31938/66A patent/GB1140387A/en not_active Expired
- 1966-07-20 ES ES329299A patent/ES329299A1/en not_active Expired
- 1966-07-20 BE BE684415D patent/BE684415A/xx unknown
- 1966-07-22 NL NL6610324A patent/NL6610324A/xx unknown
- 1966-07-22 BR BR181517/66A patent/BR6681517D0/en unknown
- 1966-07-22 FR FR70538A patent/FR6013M/fr not_active Expired
- 1966-07-22 FR FR70539A patent/FR1498465A/en not_active Expired
-
1968
- 1968-01-15 ES ES349322A patent/ES349322A1/en not_active Expired
- 1968-01-15 ES ES349321A patent/ES349321A1/en not_active Expired
- 1968-01-15 ES ES349314A patent/ES349314A1/en not_active Expired
- 1968-01-15 NL NL6800589A patent/NL6800589A/xx unknown
- 1968-01-15 ES ES349320A patent/ES349320A1/en not_active Expired
- 1968-01-15 ES ES349316A patent/ES349316A1/en not_active Expired
- 1968-01-15 ES ES349319A patent/ES349319A1/en not_active Expired
- 1968-01-15 ES ES349318A patent/ES349318A1/en not_active Expired
- 1968-01-15 ES ES349317A patent/ES349317A1/en not_active Expired
- 1968-01-16 FR FR136259A patent/FR94123E/en not_active Expired
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847264A (en) * | 1982-07-21 | 1989-07-11 | Rorer Pharmaceutical Corporation | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
US4624956A (en) * | 1983-12-16 | 1986-11-25 | Farmitalia Carlo Erba | Ulcer and gastric secretion inhibiting 4,5,6,7-tetrahydrothiazole[5,4-c]pyridine derivatives |
GB2173187A (en) * | 1985-03-23 | 1986-10-08 | Erba Farmitalia | Condensed 2-substituted thiazole derivatives |
US7291734B2 (en) | 2002-11-14 | 2007-11-06 | Novartis Ag | N-sulfonylaminothiazole |
US7727979B2 (en) | 2003-03-20 | 2010-06-01 | Actelion Pharmaceuticals Ltd. | Guanidine derivatives and their use as neuropeptide FF receptor antagonists |
WO2004083218A1 (en) * | 2003-03-20 | 2004-09-30 | Actelion Pharmaceuticals Ltd | Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
JP2006520330A (en) * | 2003-03-20 | 2006-09-07 | アクテリオン ファマシューティカルズ リミテッド | Guanidine derivatives and their use as neuropeptide FF receptor antagonists |
US7547786B2 (en) | 2003-11-12 | 2009-06-16 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
US7678910B2 (en) | 2003-11-12 | 2010-03-16 | Daiichi Sankyo Company, Limited | Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]Pyridine-2-carboxylic acid |
US7880005B2 (en) | 2003-11-12 | 2011-02-01 | Daiichi Sankyo Company, Limited | Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid |
US8058440B2 (en) | 2003-11-12 | 2011-11-15 | Daiichi Sankyo Company, Limited | Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid |
US8541592B2 (en) | 2005-11-22 | 2013-09-24 | Amgen Inc. | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
WO2010071822A1 (en) * | 2008-12-19 | 2010-06-24 | Schering Corporation | Piperidine and piperazine derivatives and methods of use thereof |
US20110245267A1 (en) * | 2008-12-19 | 2011-10-06 | Schering Plough Corporation | Piperidine and piperazine derivatives and methods of use thereof |
WO2010114971A1 (en) * | 2009-04-03 | 2010-10-07 | Sepracor Inc. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
ES349321A1 (en) | 1969-04-01 |
ES349318A1 (en) | 1969-04-01 |
BR6681517D0 (en) | 1973-12-27 |
NL6610324A (en) | 1967-01-24 |
ES329299A1 (en) | 1968-02-16 |
ES349317A1 (en) | 1969-04-01 |
NL6800589A (en) | 1968-07-17 |
DE1620508A1 (en) | 1969-09-18 |
FR1498465A (en) | 1967-10-20 |
FR6013M (en) | 1968-05-06 |
BE684415A (en) | 1967-01-20 |
ES349319A1 (en) | 1969-04-01 |
ES349314A1 (en) | 1969-04-01 |
FR94123E (en) | 1969-07-04 |
ES349316A1 (en) | 1969-04-01 |
ES349322A1 (en) | 1969-04-01 |
ES349320A1 (en) | 1969-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1140387A (en) | 4,5,6,7-tetrahydro-thiazolo-[5,4-c]pyridines | |
FI893361A (en) | Process for Preparation of ACAT Inhibiting Quinoline Derivatives | |
IE37572B1 (en) | 1-aminouracil compounds a process for their production and their use as herbicides | |
GB1053085A (en) | ||
GB1340596A (en) | Tetrahydrobenzothiazolyl derivatives and their use as herbicides | |
GB1366062A (en) | 1-acyl-3-amino-sulphonyl-2-imino-benzimidazolines process for their production and their use as fungicides | |
GB1470544A (en) | Sulphonic acid esters | |
IE36127L (en) | 3-benzylpyridines | |
GB1341884A (en) | Herbicidal 1,2,4-thiadiazolyl derivatives | |
GB1325386A (en) | Quinazoline derivatives processes for producing them and compositions containing them | |
IE38531L (en) | Production of n-chloroformyl-carbamic acid amides | |
GB1225699A (en) | ||
GB1345144A (en) | Sulphobenzoic acid derivatives | |
GB1296371A (en) | ||
JPS5236684A (en) | Process for preparation of novel penicillins and cephalosporins | |
GB1229996A (en) | ||
GB915806A (en) | Improvements relating to various forms of synthetic polyamides | |
GB1361249A (en) | 3-sulphoalkyl-6-hydroxy-pyrid--2--ones their manufacture and use | |
ES317079A1 (en) | Alpha-carboxyacylamino penicillins | |
GB1253855A (en) | New heterocyclic amines and compositions containing them, their production and use | |
GB1205519A (en) | Novel 1,2-dihydro-benztriazine derivatives and process for preparing the same | |
JPS52106883A (en) | Novel penicillins and cephalosporins | |
ES2002912A6 (en) | Acetic acid thioesters as starting materials for cephalosporins | |
GB1394825A (en) | Lactam derivatives | |
GB1382974A (en) | Process for the production of thiosemicarbazides |